Oncology
From the Journals
More type 2 diabetes deaths from cancer than heart disease
In people with type 2 diabetes, cancer screening should get at least as much attention as CVD prevention.
Commentary
75 years: A look back on the fascinating history of methotrexate and folate antagonists
Dr. David Warmflash recounts how the meandering path of early research into chemotherapy for hematologic malignancies later led to methotrexate’s...
Opinion
My patient chose quality of life over treatment
The patient’s voice has great value in the clinic and in research. Here are a few examples.
Opinion
If we care about cancer patients, we must care about climate change
Findings from the 2022 Lancet Countdown on health and climate change have been issued.
Feature
Canadian guidance recommends reducing alcohol consumption
Consuming no drinks per week has benefits.
From the Journals
Over half of ED visits from cancer patients could be prevented
The number of potentially preventable ED visits documented each year increased over the period that the authors of the new research studied.
From the Journals
Does appendectomy raise the risk for colorectal cancer?
Researchers observed a 73% increase in CRC risk among appendectomy cases, compared with controls over a 20-year follow-up.
Latest News
People with cancer should be wary of taking dietary supplements
Many patients still think over-the-counter vitamins, minerals, or herbal remedies will help.
News
Tucatinib plus trastuzumab approved for HER2+ colorectal cancer
This is the first FDA-approved treatment for HER2-positive metastatic colorectal cancer.
Latest News
Long-pulsed 1,064 nm Nd:YAG for nonaggressive BCC ‘effective and easy’
In the future, Dr. Arisa E. Ortiz and colleagues plan to evaluate the use of gold nanoparticles to more selectively target BCC during treatment....
From the Journals
Do biologics protect against cancer progression in IBD?
“These results indicate that biologics and 5-ASA are drugs that are potentially associated with a lower risk of advanced cancer in patients with...